Please find attached the latest AGM presentation and the updated corporate video in the ASX announcement by clicking in this link Or by visiting our investor page: https://www.bluechiip.com/investor/company-overview/
Discover More >Please donwload the Quarterly Acitivity Report and Appendix 4C released on the ASX on the 29th of October 2020 here
Discover More >Bluechiip is proud to announce our ISO9001:2015 certification with number FS 730393 has been officially granted. Congratulacions to everyone involved.
Discover More >Notice of Annual General Meeting and Proxy Form Attached are the following documents in relation to the Company’s Annual General Meeting: Notice of Annual General Meeting; and Proxy Form Download the ASX anouncemnt: Notice of Annual General Meeting and Proxy Form Download the ASX announcement: Cover Letter and Proxy Form Approved for release on behalf…
Discover More >Please download the Open Briefing Interview with Andrew McLellan released as an ASX announcement by clicking HERE.
Discover More >Please download the full open Briefing Interview with Andrew McLellan here: https://www.asx.com.au/asxpdf/20200428/pdf/44h97h6dwdbm7h.pdf
Discover More >Please download the report here: https://www.asx.com.au/asxpdf/20200428/pdf/44h979j2r75qdc.pdf
Discover More >Market Update ASX announcement in response to the COVID-19 pandemic. Please read the full ASX announcement here: https://www.asx.com.au/asxpdf/20200319/pdf/44g69stvkjdhrm.pdf Bluechiip Limited [ASX:BCT], a leader in the development of sample tracking technology for harsh environments, provides this update to the Australian Securities Exchange. The effects of the COVID-19 pandemic continue to evolve at a rapid pace. Key…
Discover More >Thursday, December 5th, 20198 am Pacific US, 11 am Easter US, 17:00 Central European Time This is a joined webinar championed by Agilent and with TTP Labtech and Bluechiip as expert panelists https://www.workcast.com/register?cpak=5631209160599100&referrer=800 The growing importance of biobanks to research cannot be overstated. This expanding relevance is accompanied by increasing pressure for biobanks to deliver…
Discover More >Bluechiip raises $4.5M through thte Share Purchase Plan (SPP), $9.1M in total including the proceeds of placement. Download the ASX announcement HERE: https://www.asx.com.au/asxpdf/20191120/pdf/44br9vmcrctzd1.pdf Bluechiip Limited (Bluechiip or the Company, ASX: BCT) is pleased to report the successful completion of the recently announced Share Purchase Plan (SPP), which raised $4.5 million. The SPP, which was announced…
Discover More >